RA Capital Management, L.P., Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 21,654 shares at $8.97 ($194K) on 2026-07-10, disclosed to the SEC on 2026-07-14.
Open-market purchase of $194k ARTV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.97 | 15,102 | $135K | 69.8% |
| 2 | $8.94 | 6,552 | $59K | 30.2% |
| Total | $8.96 avg | 21,654 | $194K | 100% |
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $2.6M | — | Filing → |